ResMed Reports Q1 FY2027 Financial Results and Declares Quarterly Dividend

Executive Summary

On October 29, 2026, ResMed Inc. (NYSE: RMD) filed a Current Report on Form 8-K under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). The report outlines financial results for the first quarter of fiscal year 2027 (ended September 30, 2026) and announces a quarterly cash dividend of $0.66 per share.

Key Financial Highlights (Q1 FY2027 vs. Q1 FY2026)

• Net Revenue: $1,414.8 million, up 6% YoY from $1,335.6 million (up 7% on a core constant currency basis, excluding the Noctrix acquisition and MatrixCare divestiture).
• GAAP Gross Margin: 61.5%, up 30 basis points from 61.2% in Q1 FY2026. Non-GAAP gross margin reached 62.5% (+50 bps YoY).
• Operating Income: GAAP operating income totaled $453.0 million (+1% YoY) with an operating margin of 32.0%. Non-GAAP operating income reached $506.0 million (+5% YoY) with an operating margin of 35.8%.
• Net Income & EPS:
  • GAAP Net Income: $418.4 million (+20% YoY), yielding diluted EPS of $2.92 (+23% YoY).
  • Non-GAAP Net Income: $418.0 million (+12% YoY), yielding non-GAAP diluted EPS of $2.91 (+14% YoY).
• Cash Flow & Capital Allocation:
  • Operating cash flow was $422 million, and free cash flow reached $374 million.
  • ResMed returned over $1.0 billion to shareholders during the quarter via share repurchases and dividends, aided by proceeds from the MatrixCare divestiture.

Fiscal Year 2027 Guidance

ResMed reiterated its full-year guidance:

• Reported Revenue: $5.75 billion to $5.85 billion.
• Core Constant Currency Growth: 5% to 7%.
• Non-GAAP Diluted EPS: $12.00 to $12.25.

Dividend Declaration

• Dividend Rate: US $0.66 per common share.
• Record Date: November 12, 2026.
• Payable Date: December 17, 2026.
• Ex-Dividend Date: November 11, 2026.
• CDI Holders: Holders of CHESS Depositary Interests on the ASX will receive the Australian currency equivalent reflecting the 10:1 ratio between CDIs and NYSE common shares.